Samuel D Isaly - Net Worth and Insider Trading

Samuel D Isaly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Samuel D Isaly owns 43 companies in total, including Xtant Medical Holdings Inc (XTNT) , Kala Bio Inc (KALA) , and Pieris Pharmaceuticals Inc (PIRS) among others .

Click here to see the complete history of Samuel D Isaly’s form 4 insider trades.

Insider Ownership Summary of Samuel D Isaly

Ticker Comapny Transaction Date Type of Owner
XTNT Xtant Medical Holdings Inc 2018-01-17 10 percent owner
KALA Kala Bio Inc 2017-07-25 10 percent owner & other: See Remarks
PIRS Pieris Pharmaceuticals Inc 2015-07-06 director & 10 percent owner
LOXO Loxo Oncology Inc 2017-12-08 director
SCPH scPharmaceuticals Inc 2017-11-16 10 percent owner
XFOR X4 Pharmaceuticals Inc 2017-11-15 10 percent owner
RYTM Rhythm Pharmaceuticals Inc 2017-10-04 10 percent owner
ROKA Sorrento Tech Inc 2017-10-03 10 percent owner
BOLD Audentes Therapeutics Inc 2017-09-29 10 percent owner
GKOS Glaukos Corp 2016-08-03 director
SYBX Synlogic Inc 2017-08-28 director
ALPN Alpine Immune Sciences Inc 2017-07-24 director
CTIC CTI BioPharma Corp 2017-06-09 10 percent owner
STDY SteadyMed Ltd 2017-04-25 10 percent owner
ADAP Adaptimmune Therapeutics PLC 2016-05-20 director
ARPO Aerpio Pharmaceuticals Inc 2017-03-15 director & 10 percent owner
SYRE Spyre Therapeutics Inc 2017-02-16 10 percent owner
VRAYQ ViewRay Inc 2016-08-22 director & 10 percent owner
NBRVF Nabriva Therapeutics PLC 2016-12-30 director & 10 percent owner
RPBIF Response Biomedical Corp 2016-11-29 director & 10 percent owner
RLYP Relypsa Inc 2016-07-22 10 percent owner
RNAC Cartesian Therapeutics Inc 2016-06-27 director & 10 percent owner
CRVS Corvus Pharmaceuticals Inc 2016-05-18 director
NTLA Intellia Therapeutics Inc 2016-05-05 10 percent owner
OTIC Otonomy Inc 2015-11-17 director
DMTX Dimension Therapeutics Inc 2015-10-27 director & 10 percent owner
SIENQ Sientra Inc 2014-10-28 10 percent owner
SRRA Sierra Oncology Inc 2015-07-15 director
ICPT Intercept Pharmaceuticals Inc 2013-04-09 director & 10 percent owner
MRTX Mirati Therapeutics Inc 2013-07-12 10 percent owner
XLRN Acceleron Pharma Inc 2013-09-24 other: Former 10% Owner
SUPN Supernus Pharmaceuticals Inc 2012-04-30 10 percent owner
ANTH Anthera Pharmaceuticals Inc 2013-01-30 director
AMRN Amarin Corp PLC 2011-01-01 director & 10 percent owner
PCRX Pacira BioSciences Inc 2011-02-02 10 percent owner
CCXI ChemoCentryx Inc 2012-02-08 10 percent owner
ATHXQ Athersys Inc 2008-05-13 director & 10 percent owner
NXTM NxStage Medical Inc 2010-12-09 director
KURU Kun Run Biotechnology Inc 2010-04-30 10 percent owner
ALBO Albireo Pharma Inc 2008-02-12 director & 10 percent owner
ARYX ARYx Therapeutics Inc 2009-05-22 10 percent owner
PODD Insulet Corp 2007-05-14 director
AADI Aadi Bioscience Inc 2017-03-15 director & 10 percent owner

Samuel D Isaly Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Samuel D Isaly Ownership Network

Ownership Network List of Samuel D Isaly

No Data

Ownership Network Relation of Samuel D Isaly


Samuel D Isaly Owned Company Details

What does Xtant Medical Holdings Inc do?

Who are the key executives at Xtant Medical Holdings Inc?

Samuel D Isaly is the 10 percent owner of Xtant Medical Holdings Inc. Other key executives at Xtant Medical Holdings Inc include VP & Chief Commercial Officer Kevin D Brandt , Interim CFO Scott C Neils , and Chief Operations Officer Mark A. Schallenberger .

Xtant Medical Holdings Inc (XTNT) Insider Trades Summary

Over the past 18 months, Samuel D Isaly made no insider transaction in Xtant Medical Holdings Inc (XTNT). Other recent insider transactions involving Xtant Medical Holdings Inc (XTNT) include a net purchase of 41,670 shares made by Kevin D Brandt , and a net sale of 8,673 shares made by Scott C Neils .

In summary, during the past 3 months, insiders sold 0 shares of Xtant Medical Holdings Inc (XTNT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,673 shares of Xtant Medical Holdings Inc (XTNT) were sold and 41,670 shares were bought by its insiders, resulting in a net purchase of 32,997 shares.

Xtant Medical Holdings Inc (XTNT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Xtant Medical Holdings Inc Insider Transactions

No Available Data

Samuel D Isaly Mailing Address

Above is the net worth, insider trading, and ownership report for Samuel D Isaly. You might contact Samuel D Isaly via mailing address: 601 Lexington Avenue, 54th Floor, New York Ny 10022.

Discussions on Samuel D Isaly

No discussions yet.